Medicare Part D's Effects on Elderly Drug Costs and Utilization
Author
Abstract
Suggested Citation
Note: EH
Download full text from publisher
References listed on IDEAS
- Mark Duggan & Fiona Scott Morton, 2010.
"The Effect of Medicare Part D on Pharmaceutical Prices and Utilization,"
American Economic Review, American Economic Association, vol. 100(1), pages 590-607, March.
- Mark Duggan & Fiona Scott Morton, 2008. "The Effect of Medicare Part D on Pharmaceutical Prices and Utilization," NBER Working Papers 13917, National Bureau of Economic Research, Inc.
- Helen Levy & David Weir, 2007. "Take-Up of Medicare Part D and the SSA Subsidy: Early Results from the Health and Retirement Study," Working Papers wp163, University of Michigan, Michigan Retirement Research Center.
- Tomas J. Philipson & Dana Goldman, 2007.
"Integrated Insurance Design in the Presence of Multiple Medical Technologies,"
American Economic Review, American Economic Association, vol. 97(2), pages 427-432, May.
- Dana Goldman & Tomas Philipson, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," NBER Working Papers 12870, National Bureau of Economic Research, Inc.
- Margaret E. Blume-Kohout & Neeraj Sood, 2008. "The Impact of Medicare Part D on Pharmaceutical R&D," NBER Working Papers 13857, National Bureau of Economic Research, Inc.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
- Abe Dunn & Adam Hale Shapiro, 2019.
"Does Medicare Part D Save Lives?,"
American Journal of Health Economics, MIT Press, vol. 5(1), pages 126-164, Winter.
- Abe Dunn & Adam Hale Shapiro, 2019. "Does Medicare Part D Save Lives?," American Journal of Health Economics, University of Chicago Press, vol. 5(1), pages 126-164, Winter.
- Abe Dunn & Adam Hale Shapiro, 2015. "Does Medicare Part D Save Lives?," BEA Working Papers 0119, Bureau of Economic Analysis.
- Abe Dunn & Adam Hale Shapiro, 2015. "Does Medicare Part D save lives?," Working Paper Series 2015-4, Federal Reserve Bank of San Francisco.
- Gary V. Engelhardt & Jonathan Gruber, 2010. "Medicare Part D and the Financial Protection of the Elderly," NBER Working Papers 16155, National Bureau of Economic Research, Inc.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2018.
"Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 122-153, August.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
- Banerjee, Tannista & Siebert, Ralph, 2017. "Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry," Research Policy, Elsevier, vol. 46(7), pages 1255-1271.
- Doiron, Denise & Fiebig, Denzil G. & Suziedelyte, Agne, 2014.
"Hips and hearts: The variation in incentive effects of insurance across hospital procedures,"
Journal of Health Economics, Elsevier, vol. 37(C), pages 81-97.
- Denise Doiron & Denzil G Fiebig & Agne Suziedelyte, 2013. "Hips and hearts: the variation in incentive effects of insurance across hospital procedures," Discussion Papers 2013-14, School of Economics, The University of New South Wales.
- Darius Lakdawalla & Wesley Yin, 2009. "Insurer Bargaining and Negotiated Drug Prices in Medicare Part D," NBER Working Papers 15330, National Bureau of Economic Research, Inc.
- Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.
- Alpert, Abby, 2016. "The anticipatory effects of Medicare Part D on drug utilization," Journal of Health Economics, Elsevier, vol. 49(C), pages 28-45.
- Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj, 2023.
"Prescription drug advertising and drug utilization: The role of Medicare Part D,"
Journal of Public Economics, Elsevier, vol. 221(C).
- Abby Alpert & Darius Lakdawalla & Neeraj Sood, 2015. "Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D," NBER Working Papers 21714, National Bureau of Economic Research, Inc.
- David B. Ridley, 2015. "Payments, Promotion, And The Purple Pill," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 86-103, January.
- Hall Anne E., 2016. "Estimating Regression-Based Medical Care Expenditure Indexes for Medicare Advantage Enrollees," Forum for Health Economics & Policy, De Gruyter, vol. 19(2), pages 261-297, December.
- Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
- Robert Kaestner & Cuping Schiman & G. Caleb Alexander, 2019.
"Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D,"
Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 86(3), pages 595-628, September.
- Robert Kaestner & Cuiping Long & G. Caleb Alexander, 2014. "Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D," NBER Working Papers 19948, National Bureau of Economic Research, Inc.
- Francesco Decarolis & Maria Polyakova & Stephen P. Ryan, 2020.
"Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D,"
Journal of Political Economy, University of Chicago Press, vol. 128(5), pages 1712-1752.
- Francesco Decarolis & Maria Polyakova & Stephen P. Ryan, 2015. "Subsidy Design in Privately-Provided Social Insurance: Lessons from Medicare Part D," NBER Working Papers 21298, National Bureau of Economic Research, Inc.
- Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020.
"How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D,"
Journal of Health Economics, Elsevier, vol. 71(C).
- David Powell & Rosalie Liccardo Pacula & Erin Taylor, 2015. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D," NBER Working Papers 21072, National Bureau of Economic Research, Inc.
- David Powell & Rosalie Liccardo Pacula & Erin Audrey Taylor, 2016. "How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic Evidence from Medicare Part D," Working Papers WR-1169, RAND Corporation.
- Gary V. Engelhardt & Jonathan Gruber, 2009. "Medicare Part D and the Financial Protection of the Elderly," Working Papers, Center for Retirement Research at Boston College wp2009-24, Center for Retirement Research, revised Oct 2009.
- Darius Lakdawalla & Wesley Yin, 2015.
"Insurers’ Negotiating Leverage and the External Effects of Medicare Part D,"
The Review of Economics and Statistics, MIT Press, vol. 97(2), pages 314-331, May.
- Darius N. Lakdawalla & Wesley Yin, 2010. "Insurers' Negotiating Leverage and the External Effects of Medicare Part D," NBER Working Papers 16251, National Bureau of Economic Research, Inc.
- Wesley Yin & Darius Lakdawalla, 2011. "Insurers’ Negotiating Leverage and the External Effects of Medicare Part D," Boston University - Department of Economics - Working Papers Series WP2011-065, Boston University - Department of Economics.
- Gary V. Engelhardt & Jonathan Gruber, 2011. "Medicare Part D and the Financial Protection of the Elderly," American Economic Journal: Economic Policy, American Economic Association, vol. 3(4), pages 77-102, November.
- Claudio Lucarelli & Sean Nicholson & Minjae Song, 2010. "Bundling Among Rivals: A Case of Pharmaceutical Cocktails," NBER Working Papers 16321, National Bureau of Economic Research, Inc.
- David Dranove & Craig Garthwaite & Manuel I. Hermosilla, 2020. "Expected Profits and The Scientific Novelty of Innovation," NBER Working Papers 27093, National Bureau of Economic Research, Inc.
- Florian Heiss & Daniel McFadden & Joachim Winter, 2009. "Regulation of private health insurance markets: Lessons from enrollment, plan type choice, and adverse selection in Medicare Part D," NBER Working Papers 15392, National Bureau of Economic Research, Inc.
- Ghosh, Ausmita & Simon, Kosali & Sommers, Benjamin D., 2019. "The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions," Journal of Health Economics, Elsevier, vol. 63(C), pages 64-80.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Kurt Lavetti & Kosali Simon, 2018.
"Strategic Formulary Design in Medicare Part D Plans,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 154-192, August.
- Kurt Lavetti & Kosali Simon, 2016. "Strategic Formulary Design in Medicare Part D Plans," NBER Working Papers 22338, National Bureau of Economic Research, Inc.
- Newhouse, Joseph Paul & Berndt, Ernst R., 2010.
"Pricing and Reimbursement in U.S. Pharmaceutical Markets,"
Scholarly Articles
4450127, Harvard Kennedy School of Government.
- Ernst R. Berndt & Joseph P. Newhouse, 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," NBER Working Papers 16297, National Bureau of Economic Research, Inc.
- Berndt, Ernst R. & Newhouse, Joseph P., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Working Paper Series rwp10-039, Harvard University, John F. Kennedy School of Government.
- Joseph P. Newhouse, 2021.
"An Ounce of Prevention,"
Journal of Economic Perspectives, American Economic Association, vol. 35(2), pages 101-118, Spring.
- Joseph P. Newhouse, 2020. "An Ounce of Prevention," NBER Working Papers 27553, National Bureau of Economic Research, Inc.
- Basu, Anirban & Jena, Anupam B. & Philipson, Tomas J., 2011.
"The impact of comparative effectiveness research on health and health care spending,"
Journal of Health Economics, Elsevier, vol. 30(4), pages 695-706, July.
- Anirban Basu & Tomas J. Philipson, 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending," NBER Working Papers 15633, National Bureau of Economic Research, Inc.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2018.
"Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 122-153, August.
- Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
- Boone, Jan, 2015.
"Basic versus supplementary health insurance: Moral hazard and adverse selection,"
Journal of Public Economics, Elsevier, vol. 128(C), pages 50-58.
- Boone, Jan, 2014. "Basic versus supplementary health insurance: moral hazard and adverse selection," CEPR Discussion Papers 10199, C.E.P.R. Discussion Papers.
- Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Discussion Paper 2014-059, Tilburg University, Center for Economic Research.
- Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Discussion Paper 2014-034, Tilburg University, Tilburg Law and Economic Center.
- Mark Egan & Tomas Philipson, 2016. "Health Care Adherence and Personalized Medicine," Working Papers 2016-H01, Becker Friedman Institute for Research In Economics.
- Clément de Chaisemartin & Xavier D'Haultfœuille, 2020.
"Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects,"
American Economic Review, American Economic Association, vol. 110(9), pages 2964-2996, September.
- Cl'ement de Chaisemartin & Xavier D'Haultf{oe}uille, 2018. "Two-way fixed effects estimators with heterogeneous treatment effects," Papers 1803.08807, arXiv.org, revised Mar 2020.
- Clément de Chaisemartin & Xavier D'Haultfoeuille, 2019. "Two-way Fixed Effects Estimators with Heterogeneous Treatment Effects," NBER Working Papers 25904, National Bureau of Economic Research, Inc.
- Darius Lakdawalla & Wesley Yin, 2015.
"Insurers’ Negotiating Leverage and the External Effects of Medicare Part D,"
The Review of Economics and Statistics, MIT Press, vol. 97(2), pages 314-331, May.
- Darius N. Lakdawalla & Wesley Yin, 2010. "Insurers' Negotiating Leverage and the External Effects of Medicare Part D," NBER Working Papers 16251, National Bureau of Economic Research, Inc.
- Wesley Yin & Darius Lakdawalla, 2011. "Insurers’ Negotiating Leverage and the External Effects of Medicare Part D," Boston University - Department of Economics - Working Papers Series WP2011-065, Boston University - Department of Economics.
- Ellis, Randall P. & Manning, Willard G., 2007. "Optimal health insurance for prevention and treatment," Journal of Health Economics, Elsevier, vol. 26(6), pages 1128-1150, December.
- Kristopher J. Hult & Tomas J. Philipson, 2012. "Public Liabilities and Health Care Policy," NBER Working Papers 18571, National Bureau of Economic Research, Inc.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," NBER Working Papers 20159, National Bureau of Economic Research, Inc.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2015.
"Behavioral Hazard in Health Insurance,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(4), pages 1623-1667.
- Katherine Baicker & Sendhil Mullainathan & Joshua Schwartzstein, 2012. "Behavioral Hazard in Health Insurance," NBER Working Papers 18468, National Bureau of Economic Research, Inc.
- Brandon Pope & Abhijit Deshmukh & Andrew Johnson & James Rohack, 2014. "Multilateral Contracting And Prevention," Health Economics, John Wiley & Sons, Ltd., vol. 23(4), pages 397-409, April.
- Hermosilla, Manuel & Wu, Yufei, 2018. "Market size and innovation: The intermediary role of technology licensing," Research Policy, Elsevier, vol. 47(5), pages 980-991.
- Limbrock Frank, 2011. "Pecuniary and Non-Pecuniary Incentives in Prescription Pharmaceuticals: The Case of Statins," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 11(2), pages 1-30, January.
- Lakdawalla, Darius & Sood, Neeraj, 2009. "Innovation and the welfare effects of public drug insurance," Journal of Public Economics, Elsevier, vol. 93(3-4), pages 541-548, April.
- Marika Cabral & Mark R. Cullen, 2017. "The Effect Of Insurance Coverage On Preventive Care," Economic Inquiry, Western Economic Association International, vol. 55(3), pages 1452-1467, July.
- Glazer, Jacob & McGuire, Thomas G., 2012. "A welfare measure of “offset effects” in health insurance," Journal of Public Economics, Elsevier, vol. 96(5), pages 520-523.
- Timothy J. Halliday & Randall Q. Akee, 2020.
"The impact of Medicaid on medical utilization in a vulnerable population: Evidence from COFA migrants,"
Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1231-1250, October.
- Timothy J. Halliday & Randall Q. Akee & Tetine Sentell & Megan Inada & Jill Miyamura, 2019. "The Impact of Medicaid on Medical Utilization in a Vulnerable Population: Evidence from COFA Migrants," NBER Working Papers 26030, National Bureau of Economic Research, Inc.
- Halliday, Timothy J. & Akee, Randall K. Q. & Sentell, Tetine & Inada, Megan & Miyamura, Jill, 2019. "The Impact of Medicaid on Medical Utilization in a Vulnerable Population: Evidence from COFA Migrants," IZA Discussion Papers 12779, Institute of Labor Economics (IZA).
More about this item
JEL classification:
- H42 - Public Economics - - Publicly Provided Goods - - - Publicly Provided Private Goods
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
NEP fields
This paper has been announced in the following NEP Reports:- NEP-AGE-2008-09-20 (Economics of Ageing)
- NEP-HEA-2008-09-20 (Health Economics)
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberwo:14326. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.